Medical monitor support and advice for FLU-v phase IIb study for influenza
Each year, influenza affects up to 5 million people worldwide and leads to an estimated 650,000 deaths. Currently, the most effective available treatment is an annual vaccination with inactivated and attenuated influenza virus. With the annual challenge of new strains, the efficacy of vaccines can be affected, and vaccine availability is often limited. There are a […]
